Skip to main content

Infuvite Pediatric Dosage

Generic name: ASCORBIC ACID 80mg in 4mL, VITAMIN A PALMITATE 2300[iU] in 4mL, CHOLECALCIFEROL 400[iU] in 4mL, THIAMINE HYDROCHLORIDE 1.2mg in 4mL, RIBOFLAVIN 5'-PHOSPHATE SODIUM 1.4mg in 4mL, PYRIDOXINE HYDROCHLORIDE 1mg in 4mL, NIACINAMIDE 17mg in 4mL, DEXPANTHENOL 5mg in 4mL, .ALPHA.-TOCOPHEROL ACETATE 7[iU] in 4mL, PHYTONADIONE 0.2mg in 4mL; FOLIC ACID 140ug in 1mL, BIOTIN 20ug in 1mL, CYANOCOBALAMIN 1ug in 1mL
Dosage form: intravenous infusion
Drug class: Vitamin and mineral combinations

Medically reviewed by Drugs.com. Last updated on May 6, 2024.

Important Dosage Instructions

INFUVITE PEDIATRIC is a combination product that contains the following vitamins: ascorbic acid, vitamin A, vitamin D, thiamine, riboflavin, pyridoxine, niacinamide, dexpanthenol, vitamin E, vitamin K1, folic acid, biotin, and vitamin B12 .

INFUVITE PEDIATRIC is supplied as a single dose or as a pharmacy bulk package, for intravenous use intended for administration by intravenous infusion after dilution:

  • INFUVITE PEDIATRIC Single Dose consists of two vials. A weight-based volume from each vial must be added directly to dextrose or saline solution prior to intravenous administration [ see Dosage and Administration ( 2.2, 2.3) ].
  • INFUVITE PEDIATRIC Pharmacy Bulk Package consists of two pharmacy bulk vials which must be mixed prior to use. The mixed solution will provide multiple daily doses which must be diluted prior to intravenous administration. Pharmacy bulk package of INFUVITE PEDIATRIC is intended for dispensing of single doses to multiple patients in a pharmacy admixture program and is restricted to the preparation of admixtures for infusion. [ see Dosage and Administration ( 2.2, 2.3) ].

Dosage Information

The recommended daily dosage volume is based on the patient's actual weight less than 1 kg, 1 kg to less than 3 kg, and 3 kg or greater.

Patients with multiple vitamin deficiencies or with increased vitamin requirements may need multiple daily dosages as indicated or additional doses of individual vitamins. Supplemental vitamin A may be required for low-birth weight infants.

Additional daily dosages of Vitamin E in infants are not recommended.

INFUVITE PEDIATRIC Single Dose (see Table 1):

One daily dose of Vial 1 (1.2 mL, 2.6 mL or 4 mL) and one daily dose of Vial 2 (0.3 mL, 0.65 mL or 1 mL) based on the patient’s weight are added directly to a specified volume of an intravenous fluid [ see Dosage and Administration ( 2.3) ] (see Table 1).

Table : Recommended Weight-Based Dosage of INFUVITE PEDIATRIC Single Dose

Less than 1 kg

1 kg to less than 3 kg

3 kg or greater

Daily Dosage Volume – Vial 1

1.2 mL

2.6 mL

4 mL

Ascorbic acid (Vitamin C)

24 mg

52 mg

80 mg

Vitamin A (as palmitate)

690 IU (equals 0.2 mg)

1495 IU (equals 0.5 mg)

2,300 IU (equals 0.7 mg)

Vitamin D 3 (cholecalciferol)

120 IU (equals 3 mcg)

260 IU (equals 7 mc g)

400 IU (equals 10 mcg)

Thiamine (Vitamin B 1) (as the hydrochloride)

0.4 mg

0.8 mg

1.2 mg

Riboflavin (Vitamin B 2) (as riboflavin 5-phosphate sodium)

0.4 mg

0.9 mg

1.4 mg

Pyridoxine HCl (Vitamin B 6)

0.3 mg

0.7 mg

1 mg

Niacinamide

5.1 mg

11.1 mg

17 mg

Dexpanthenol (as d-pantothenyl alcohol)

1.5 mg

3.3 mg

5 mg

Vitamin E ( dl-α-tocopheryl acetate)

2.1 IU (equals 2 mg)

4.6 IU (equals 5 mg)

7 IU (equals 7 mg)

Vitamin K 1

0.1 mg

0.1 mg

0.2 mg

Daily Dosage Volume – Vial 2

0.3 mL

0.65 mL

1 mL

Folic acid

42 mcg

91 mcg

140 mcg

Biotin

6 mcg

13 mcg

20 mcg

Vitamin B12 (cyanocobalamin)

0.3 mcg

0.7 mcg

1 mcg

INFUVITE PEDIATRIC Pharmacy Bulk Package (see Table 2):

The recommended daily dosage volume of combined content of vials 1 and 2 (1.5 mL, 3.25 mL or 5 mL) is based on the patient’s weight and then added directly to the specific volume of an intravenous fluid [ see Dosage and Administration ( 2.3) ].

Table : Recommended Weight-Based Dosage of INFUVITE PEDIATRIC Pharmacy Bulk Package

Less than 1 kg

1 kg to less than 3 kg

3 kg or greater

Daily Dosage Volume(combined contents of Vial 1 and Vial 2)

1.5 mL

3.25 mL

5 mL

Ascorbic acid (Vitamin C)

24 mg

52 mg

80 mg

Vitamin A (as palmitate)

690 IU (equals 0.2 mg)

1495 IU (equals 0.5 mg)

2,300 IU (equals 0.7 mg)

Vitamin D 3 (cholecalciferol)

120 IU (equals 3 mcg)

260 IU (equals 7 mc g)

400 IU (equals 10 mcg)

Thiamine (Vitamin B 1) (as the hydrochloride)

0.4 mg

0.8 mg

1.2 mg

Riboflavin (Vitamin B 2) (as riboflavin 5-phosphate sodium)

0.4 mg

0.9 mg

1.4 mg

Pyridoxine HCl (Vitamin B 6)

0.3 mg

0.7 mg

1 mg

Niacinamide

5.1 mg

11.1 mg

17 mg

Dexpanthenol (as d-pantothenyl alcohol)

1.5 mg

3.3 mg

5 mg

Vitamin E ( dl-α-tocopheryl acetate)

2.1 IU (equals 2 mg)

4.6 IU (equals 5 mg)

7 IU (equals 7 mg)

Vitamin K 1

0.1 mg

0.1 mg

0.2 mg

Folic acid

42 mcg

91 mcg

140 mcg

Biotin

6 mcg

13 mcg

20 mcg

Vitamin B12 (cyanocobalamin)

0.3 mcg

0.7 mcg

1 mcg

Preparation and Administration Instructions

Do not administer INFUVITE PEDIATRIC as a direct, undiluted intravenous injection as it may cause dizziness, faintness, and possible tissue irritation.

  1. INFUVITE PEDIATRIC Single Dose:
  2. Use only in a suitable work area such as a laminar flow hood (or an equivalent clean air compounding area).
  3. Add one weight-based dose of Vial 1 (1.2 mL, 2.6 mL or 4 mL) and one weight-based dose of Vial 2 (0.3 mL, 0.65 mL or 1 mL) directly to at least 100 mL of intravenous dextrose or saline solution.
  4. Discard unused portion.
  5. Visually inspect for particulate matter and discoloration prior to administration.
  6. After INFUVITE PEDIATRIC is diluted in an intravenous infusion, refrigerate the resulting solution unless it is to be used immediately, and use the solution within 24 hours after dilution.
  7. Minimize exposure to light because some of the vitamins in INFUVITE PEDIATRIC, particularly A, D and riboflavin, are light sensitive.
  8. INFUVITE PEDIATRIC Pharmacy Bulk Package:
  9. Use only in a suitable work area such as a laminar flow hood (or an equivalent clean air compounding area).
  10. Transfer the contents of Vial 2 (10 mL of solution) into the contents of Vial 1 (40 mL of solution). The mixed solution (50 mL) will provide thirty-three 1.5 mL single doses, fifteen 3.25 mL single doses or ten 5 mL single doses.
  11. Each bulk vial closure shall be penetrated only one time with a suitable sterile transfer device or dispensing set that allows measured dispensing of the contents.
  12. Once the closure system has been penetrated, complete dispensing from the pharmacy bulk vial should be completed within 4 hours. The mixed solution may be refrigerated and stored for up to 4 hours.
  13. Discard unused portion.
  14. Visually inspect for particulate matter and discoloration prior to administration.
  15. Add one dose directly to at least 100 mL of intravenous dextrose or saline solution for each patient.
  16. After INFUVITE PEDIATRIC is diluted in an intravenous infusion, refrigerate the resulting solution unless it is to be used immediately, and use the solution within 24 hours after dilution.
  17. Minimize exposure to light because some of the vitamins in INFUVITE PEDIATRIC, particularly A, D and riboflavin, are light sensitive.

Monitoring Vitamin Blood Levels

Blood vitamin concentrations should be monitored to ensure maintenance of adequate levels, particularly in patients receiving parenteral multivitamins as the only source of vitamins for long periods of time.

Drug Incompatibilities

  • INFUVITE PEDIATRIC is not physically compatible with moderately alkaline solutions such as a sodium bicarbonate solution and other alkaline drugs such as acetazolamide sodium, aminophylline, ampicillin sodium, tetracycline HCl and chlorothiazide sodium.
  • Folic acid is unstable in the presence of calcium salts such as calcium gluconate.
  • Vitamin A and thiamine in INFUVITE PEDIATRIC may react with bisulfite solutions such as sodium bisulfite or vitamin K bisulfite.
  • Do not add INFUVITE PEDIATRIC directly to intravenous fat emulsions.
  • Consult appropriate references for additional listings of physical and chemical compatibility of solutions and drugs with the vitamin infusion when needed. If incompatibilities are identified, avoid admixture or Y-site administration with vitamin solutions.

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.